Novartis Ag (NVS) Income from Continuing Operations (2009 - 2026)

Novartis Ag has reported Income from Continuing Operations for 18 years, with the latest figure at 3257000000.0 in Q2 2026.

• Quarterly Income from Continuing Operations fell 19.06% year-over-year to 3257000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 19723000000.0 (down 12.23% YoY) and the FY2025 annual result came in at 13967000000.0, up 16.99% from the prior year.
• Income from Continuing Operations declined to 3257000000.0 in Q2 2026 per NVS's latest filing, from 4024000000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 34001372000000.0 in Q1 2022 and troughed at 1136000000.0 in Q3 2022.
• A 5-year average of 3549147181818.18 and a median of 4436000000.0 in 2024 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations surged 142.84% in 2022, then tumbled 85.29% in 2023.
• Over 5 years, Income from Continuing Operations stood at 5585000000.0 in 2022, then climbed by 7.54% to 6006000000.0 in 2023, then jumped by 33.3% to 8006000000.0 in 2024, then plunged by 49.74% to 4024000000.0 in 2025, then slipped by 19.06% to 3257000000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 3257000000.0, 4024000000.0, and 8006000000.0 for Q2 2026, Q2 2025, and Q4 2024 respectively.